Study to restore thymus function and improve insulin control
Part of Immune system & allergy clinical trials.
This Phase 2 study tests a treatment aimed at improving immune system function and reducing insulin problems over 12 months. You may be able to join if you’re between 40 and 80 and don’t have certain diabetes, hormonal, heart, or immune conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re 40 to 80 years old and can join for the full 12 months
- You can clearly agree to take part (informed consent)
- You do not have cancer now or a strong personal/family cancer risk
- You do not have conditions linked to growth hormone problems (or recent growth hormone use in the last 5 years)
- You do not have Type 1 or long-standing pre-existing Type 2 diabetes, and you’re not on strict fasting or ketogenic diets for the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medication to see if it can improve how your body responds to insulin and boost your cells' energy (mitochondrial function). It is for adults with type 1 diabetes who are already on insulin and have good overall health.
This study tests two different medications (Anti-Thymocyte Globulin and Adalimumab or Verapamil) to see if they can slow down the loss of insulin production in people with newly diagnosed type 1 diabetes. Participants will be randomly assigned to receive one of the treatments and will be followed for about a year to see how well their bodies still make insulin.
This early-stage trial tests a combination approach to help your immune system stop attacking insulin-producing cells in newly diagnosed type 1 diabetes. It aims to preserve your body's ability to make insulin and slow disease progression.
This trial tests two FDA-approved drugs, rapamycin and everolimus, to see if they can improve immune function in healthy older adults. You may join if you are generally healthy, live independently, and are between 65 and 90 years old.
This Phase 1 study tests a new immune-system strategy around islet transplantation (or donor bone marrow therapy) to improve control of type 1 diabetes and reduce dangerous low blood sugar. It mainly aims to see if the approach is safe and helpful in people with long-standing, difficult-to-manage diabetes.
This study tests if adding a non-insulin medication can lower the amount of insulin needed while improving heart and metabolic health in people with type 1 diabetes. It may also help understand how this approach works in people with a genetic form of diabetes (GCK-MODY).
Hear when a new Epigenetic Aging trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.